celecoxib has been researched along with Injury, Myocardial Reperfusion in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results indicate that the volatile anesthetic isoflurane produces a second window of preconditioning against myocardial ischemia and reperfusion injury." | 7.72 | Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. ( Alcindor, D; Kersten, JR; Krolikowski, JG; Ludwig, LM; Pagel, PS; Pratt, PF; Tanaka, K; Warltier, DC, 2004) |
| "The results indicate that the volatile anesthetic isoflurane produces a second window of preconditioning against myocardial ischemia and reperfusion injury." | 3.72 | Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. ( Alcindor, D; Kersten, JR; Krolikowski, JG; Ludwig, LM; Pagel, PS; Pratt, PF; Tanaka, K; Warltier, DC, 2004) |
| "Pre-treatment with celecoxib completely abolished rosuvastatin's protective effect (FMD pre-IR: 8." | 2.75 | Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism. ( Gori, T; Liuni, A; Luca, MC; Parker, JD, 2010) |
| "Bradykinin pretreatment would improve post-ischemic performance, and reduced the release of LDH and infarct size." | 1.34 | [COX-2 and HO-1 are involved in the delayed preconditioning elicited by bradykinin in rat hearts]. ( Cai, ZN; Chen, YY; Dong, HZ; Shen, FR; Shen, YL; Wang, Y; Xu, HJ; Zhu, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lada-Moldovan, L | 1 |
| Kaloustian, S | 2 |
| Bah, TM | 2 |
| Girard, SA | 1 |
| Déry, MA | 1 |
| Rousseau, G | 2 |
| Liuni, A | 1 |
| Luca, MC | 1 |
| Gori, T | 1 |
| Parker, JD | 1 |
| Tanaka, K | 1 |
| Ludwig, LM | 1 |
| Krolikowski, JG | 1 |
| Alcindor, D | 1 |
| Pratt, PF | 1 |
| Kersten, JR | 1 |
| Pagel, PS | 1 |
| Warltier, DC | 1 |
| Liu, X | 1 |
| Zhou, Z | 1 |
| Feng, X | 1 |
| Jia, Z | 1 |
| Jin, Y | 1 |
| Xu, J | 1 |
| Dong, HZ | 1 |
| Chen, YY | 1 |
| Zhu, L | 1 |
| Xu, HJ | 1 |
| Wang, Y | 1 |
| Shen, FR | 1 |
| Cai, ZN | 1 |
| Shen, YL | 1 |
| Sato, H | 1 |
| Bolli, R | 1 |
| Rokosh, GD | 1 |
| Bi, Q | 1 |
| Dai, S | 1 |
| Shirk, G | 1 |
| Tang, XL | 1 |
| Wann, BP | 1 |
| Falcao, S | 1 |
| Dufort, AM | 1 |
| Ryvlin, P | 1 |
| Godbout, R | 1 |
1 trial available for celecoxib and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
Topics: Adolescent; Adult; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; En | 2010 |
6 other studies available for celecoxib and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Chronic pretreatment with celecoxib reduces infarct size.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Infusions, Parenteral; Isch | 2009 |
Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2.
Topics: Anesthetics, Inhalation; Animals; Blood Pressure; Blotting, Western; Celecoxib; Coronary Circulation | 2004 |
Cyclooxygenase-2 plays an essential part in cardioprotection of delayed phase of recombinant human erythropoietin preconditioning in rats.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Erythropoietin; Ischemic Precondi | 2006 |
[COX-2 and HO-1 are involved in the delayed preconditioning elicited by bradykinin in rat hearts].
Topics: Animals; Bradykinin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Heme Oxygenase-1; In Vi | 2007 |
The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.
Topics: Animals; Celecoxib; Consciousness; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dise | 2007 |
Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala.
Topics: Amygdala; Animals; Apoptosis; Celecoxib; Cyclooxygenase Inhibitors; Myocardial Reperfusion; Myocardi | 2007 |